G-quadruplex ligands targeting telomeres do not inhibit HIV promoter activity and cooperate with latency reversing agents in killing latently infected cells

References

• Archin NM, Kirchherr JL, Sung JA, et al. Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency. J Clin Invest. 2017;127:3126–3135.
   PubMed Web of Science ®Google Scholar
• Gutierrez C, Serrano-Villar S, Madrid-Elena N, et al. Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy. AIDS. 2016;30:1385–1392.
   PubMed Web of Science ®Google Scholar
• Elliott JH, McMahon JH, Chang CC, et al. Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study. Lancet HIV. 2015;2:e520–529.
   PubMed Web of Science ®Google Scholar
• Sogaard OS, Graversen ME, Leth S, et al. The depsipeptide romidepsin reverses HIV-1 latency in vivo. PLoS Pathog. 2015;11:e1005142.
   PubMed Web of Science ®Google Scholar
• Elliott JH, Wightman F, Solomon A, et al. Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy. PLoS Pathog. 2014;10:e1004473.
   PubMed Web of Science ®Google Scholar
• Rasmussen TA, Tolstrup M, Brinkmann CR, et al. Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial. Lancet HIV. 2014;1:e13–21.
   PubMed Web of Science ®Google Scholar
• Archin NM, Liberty AL, Kashuba AD, et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature. 2012;487:482–485.
   PubMed Web of Science ®Google Scholar
• Piekna-Przybylska D, Maggirwar SB. CD4+ memory T cells infected with latent HIV-1 are susceptible to drugs targeting telomeres. Cell Cycle. 2018;17:2187–2203.
   PubMed Web of Science ®Google Scholar
• Piekna-Przybylska D, Nagumotu K, Reid DM, et al. HIV-1 infection renders brain vascular pericytes susceptible to the extracellular glutamate. J Neurovirol. 2019;25:114–126.
   PubMed Web of Science ®Google Scholar
• Piekna-Przybylska D, Sharma G, Maggirwar SB, et al. Deficiency in DNA damage response, a new characteristic of cells infected with latent HIV-1. Cell Cycle. 2017;16:968–978.
   PubMed Web of Science ®Google Scholar
• Hu MH, Wu TY, Huang Q, et al. New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription. Nucleic Acids Res. 2019;47:10529–10542.
   PubMed Web of Science ®Google Scholar
• Lavrado J, Brito H, Borralho PM, et al. KRAS oncogene repression in colon cancer cell lines by G-quadruplex binding indolo[3,2-c]quinolines. Sci Rep. 2015;5:9696.
   PubMed Web of Science ®Google Scholar
• Bidzinska J, Cimino-Reale G, Zaffaroni N, et al. G-quadruplex structures in the human genome as novel therapeutic targets. Molecules. 2013;18:12368–12395.
   PubMed Web of Science ®Google Scholar
• Balasubramanian S, Hurley LH, Neidle S. Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? Nat Rev Drug Discov. 2011;10:261–275.
   PubMed Web of Science ®Google Scholar
• Brown RV, Danford FL, Gokhale V, et al. Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex. J Biol Chem. 2011;286:41018–41027.
   PubMed Web of Science ®Google Scholar
• Seenisamy J, Rezler EM, Powell TJ, et al. The dynamic character of the G-quadruplex element in the c-MYC promoter and modification by TMPyP4. J Am Chem Soc. 2004;126:8702–8709.
   PubMed Web of Science ®Google Scholar
• Gonzalez V, Hurley LH. The C-terminus of nucleolin promotes the formation of the c-MYC G-quadruplex and inhibits c-MYC promoter activity. Biochemistry. 2010;49:9706–9714.
   PubMed Web of Science ®Google Scholar
• Gonzalez V, Guo K, Hurley L, et al. Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein. J Biol Chem. 2009;284:23622–23635.
   PubMed Web of Science ®Google Scholar
• Thakur RK, Kumar P, Halder K, et al. Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression. Nucleic Acids Res. 2009;37:172–183.
   PubMed Web of Science ®Google Scholar
• Sun D, Liu WJ, Guo K, et al. The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex-interactive agents. Mol Cancer Ther. 2008;7:880–889.
   PubMed Web of Science ®Google Scholar
• Mikami-Terao Y, Akiyama M, Yuza Y, et al. Antitumor activity of G-quadruplex-interactive agent TMPyP4 in K562 leukemic cells. Cancer Lett. 2008;261:226–234.
   PubMed Web of Science ®Google Scholar
• Cogoi S, Xodo LE. G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription. Nucleic Acids Res. 2006;34:2536–2549.
   PubMed Web of Science ®Google Scholar
• Siddiqui-Jain A, Grand CL, Bearss DJ, et al. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc Natl Acad Sci U S A. 2002;99:11593–11598.
   PubMed Web of Science ®Google Scholar
• Grand CL, Han H, Munoz RM, et al. The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo. Mol Cancer Ther. 2002;1:565–573.
   PubMed Web of Science ®Google Scholar
• Piekna-Przybylska D, Sullivan MA, Sharma G, et al. U3 region in the HIV-1 genome adopts a G-quadruplex structure in its RNA and DNA sequence. Biochemistry. 2014;53:2581–2593.
   PubMed Web of Science ®Google Scholar
• Perrone R, Nadai M, Frasson I, et al. A dynamic G-quadruplex region regulates the HIV-1 long terminal repeat promoter. J Med Chem. 2013;56:6521–6530.
   PubMed Web of Science ®Google Scholar
• Amrane S, Kerkour A, Bedrat A, et al. Topology of a DNA G-quadruplex structure formed in the HIV-1 promoter: a potential target for anti-HIV drug development. J Am Chem Soc. 2014;136:5249–5252.
   PubMed Web of Science ®Google Scholar
• Bosque A, Planelles V. Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood. 2009;113:58–65.
   PubMed Web of Science ®Google Scholar
• Bosque A, Planelles V. Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells. Methods. 2011;53:54–61.
   PubMed Web of Science ®Google Scholar
• Piekna-Przybylska D, Bambara RA, Balakrishnan L. Acetylation regulates DNA repair mechanisms in human cells. Cell Cycle. 2016;15:1506–1517.
   PubMed Web of Science ®Google Scholar
• Piekna-Przybylska D. Reporter Assays for BER Pathway. Methods Mol Biol. 2019;1999:145–160.
   PubMedGoogle Scholar
• Zhou G, Liu X, Li Y, et al. Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells. Oncotarget. 2016;7:14925–14939.
   PubMedGoogle Scholar
• Temime-Smaali N, Guittat L, Sidibe A, et al. The G-quadruplex ligand telomestatin impairs binding of topoisomerase IIIalpha to G-quadruplex-forming oligonucleotides and uncaps telomeres in ALT cells. PLoS One. 2009;4:e6919.
   PubMed Web of Science ®Google Scholar
• Gomez D, O’Donohue MF, Wenner T, et al. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells. Cancer Res. 2006;66:6908–6912.
   PubMed Web of Science ®Google Scholar
• Yan J, Zhao X, Liu B, et al. An intramolecular G-quadruplex structure formed in the human MET promoter region and its biological relevance. Mol Carcinog. 2016;55:897–909.
   PubMed Web of Science ®Google Scholar
• Zidanloo SG, Hosseinzadeh Colagar A, Ayatollahi H, et al. Downregulation of the WT1 gene expression via TMPyP4 stabilization of promoter G-quadruplexes in leukemia cells. Tumour Biol. 2016;37:9967–9977.
   PubMedGoogle Scholar
• Li Y, Syed J, Suzuki Y, et al. Effect of ATRX and G-quadruplex formation by the VNTR sequence on alpha-globin gene expression. Chembiochem. 2016;17:928–935.
   PubMed Web of Science ®Google Scholar
• Zheng KW, Chen Z, Hao YH, et al. Molecular crowding creates an essential environment for the formation of stable G-quadruplexes in long double-stranded DNA. Nucleic Acids Res. 2010;38:327–338.
   PubMed Web of Science ®Google Scholar
• Raiber EA, Kranaster R, Lam E, et al. A non-canonical DNA structure is a binding motif for the transcription factor SP1 in vitro. Nucleic Acids Res. 2012;40:1499–1508.
   PubMed Web of Science ®Google Scholar
• Kong JN, Zhang C, Zhu YC, et al. Identification and characterization of G-quadruplex formation within the EP0 promoter of pseudorabies virus. Sci Rep. 2018;8:14029.
   PubMed Web of Science ®Google Scholar
• Tsukakoshi K, Saito S, Yoshida W, et al. CpG methylation changes g-quadruplex structures derived from gene promoters and interaction with VEGF and SP1. Molecules. 2018;23. DOI:https://doi.org/10.3390/molecules23040944
   Google Scholar
• Vorlickova M, Kejnovska I, Sagi J, et al. Circular dichroism and guanine quadruplexes. Methods. 2012;57:64–75.
   PubMed Web of Science ®Google Scholar
• Czyz M, Gniazdowski M. Actinomycin D specifically inhibits the interaction between transcription factor Sp1 and its binding site. Acta Biochim Pol. 1998;45:67–73.
   PubMed Web of Science ®Google Scholar
• Shishido T, Wolschendorf F, Duverger A, et al. Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation. J Virol. 2012;86:9055–9069.
   PubMed Web of Science ®Google Scholar
• Bouchat S, Gatot JS, Kabeya K, et al. Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4(+) T cells from HIV-1-infected HAART-treated patients. AIDS. 2012;26:1473–1482.
   PubMed Web of Science ®Google Scholar
• Reuse S, Calao M, Kabeya K, et al. Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS One. 2009;4:e6093.
   PubMed Web of Science ®Google Scholar
• Archin NM, Espeseth A, Parker D, et al. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res Hum Retroviruses. 2009;25:207–212.
   PubMed Web of Science ®Google Scholar
• Grau-Exposito J, Luque-Ballesteros L, Navarro J, et al. Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations. PLoS Pathog. 2019;15:e1007991.
   PubMed Web of Science ®Google Scholar
• Laird GM, Bullen CK, Rosenbloom DI, et al. Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations. J Clin Invest. 2015;125:1901–1912.
   PubMed Web of Science ®Google Scholar
• Darcis G, Kula A, Bouchat S, et al. An In-depth comparison of latency-reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified bryostatin-1+JQ1 and ingenol-B+JQ1 to potently reactivate viral gene expression. PLoS Pathog. 2015;11:e1005063.
   PubMed Web of Science ®Google Scholar
• Spina CA, Anderson J, Archin NM, et al. An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients. PLoS Pathog. 2013;9:e1003834.
   PubMed Web of Science ®Google Scholar
• Lee HT, Bose A, Lee CY, et al. Molecular mechanisms by which oxidative DNA damage promotes telomerase activity. Nucleic Acids Res. 2017;45:11752–11765.
   PubMed Web of Science ®Google Scholar
• Fouquerel E, Lormand J, Bose A, et al. Oxidative guanine base damage regulates human telomerase activity. Nat Struct Mol Biol. 2016;23:1092–1100.
   PubMed Web of Science ®Google Scholar
• Sarkar J, Liu Y. The origin of oxidized guanine resolves the puzzle of oxidation-induced telomere-length alterations. Nat Struct Mol Biol. 2016;23:1070–1071.
   PubMed Web of Science ®Google Scholar
• Vallabhaneni H, Zhou F, Maul RW, et al. Defective repair of uracil causes telomere defects in mouse hematopoietic cells. J Biol Chem. 2015;290:5502–5511.
   PubMed Web of Science ®Google Scholar
• Lu J, Liu Y. Deletion of Ogg1 DNA glycosylase results in telomere base damage and length alteration in yeast. Embo J. 2010;29:398–409.
   PubMed Web of Science ®Google Scholar
• Opresko PL, Fan J, Danzy S, et al. Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2. Nucleic Acids Res. 2005;33:1230–1239.
   PubMed Web of Science ®Google Scholar
• Eddy J, Maizels N. Gene function correlates with potential for G4 DNA formation in the human genome. Nucleic Acids Res. 2006;34:3887–3896.
   PubMed Web of Science ®Google Scholar
• Marsico G, Chambers VS, Sahakyan AB, et al. Whole genome experimental maps of DNA G-quadruplexes in multiple species. Nucleic Acids Res. 2019;47:3862–3874.
   PubMed Web of Science ®Google Scholar
• Coluzzi E, Buonsante R, Leone S, et al. Transient ALT activation protects human primary cells from chromosome instability induced by low chronic oxidative stress. Sci Rep. 2017;7:43309.
   PubMed Web of Science ®Google Scholar
• Bechter OE, Zou Y, Walker W, et al. Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition. Cancer Res. 2004;64:3444–3451.
   PubMed Web of Science ®Google Scholar
• Rizki A, Lundblad V. Defects in mismatch repair promote telomerase-independent proliferation. Nature. 2001;411:713–716.
   PubMed Web of Science ®Google Scholar
• Bellacosa A. Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death Differ. 2001;8:1076–1092.
   PubMed Web of Science ®Google Scholar
• Sun Y, Huang YC, Xu QZ, et al. HIV-1 Tat depresses DNA-PK(CS) expression and DNA repair, and sensitizes cells to ionizing radiation. Int J Radiat Oncol Biol Phys. 2006;65:842–850.
   PubMed Web of Science ®Google Scholar
• Zhang SM, Zhang H, Yang TY, et al. Interaction between HIV-1 Tat and DNA-PKcs modulates HIV transcription and class switch recombination. Int J Biol Sci. 2014;10:1138–1149.
   PubMed Web of Science ®Google Scholar
• Sui J, Zhang S, Chen BPC. DNA-dependent protein kinase in telomere maintenance and protection. Cell Mol Biol Lett. 2020;25:2.
   PubMed Web of Science ®Google Scholar
• Hrecka K, Hao C, Shun MC, et al. HIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins. Proc Natl Acad Sci U S A. 2016;113:E3921–3930.
   PubMed Web of Science ®Google Scholar
• Schrofelbauer B, Yu Q, Zeitlin SG, et al. Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases. J Virol. 2005;79:10978–10987.
   PubMed Web of Science ®Google Scholar
• Bouhamdan M, Benichou S, Rey F, et al. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J Virol. 1996;70:697–704.
   PubMed Web of Science ®Google Scholar
• Lv L, Wang Q, Xu Y, et al. Vpr targets TET2 for degradation by CRL4(VprBP) E3 ligase to sustain IL-6 expression and enhance HIV-1 replication. Mol Cell. 2018;70:961–970 e965.
   PubMed Web of Science ®Google Scholar
• Lahouassa H, Blondot ML, Chauveau L, et al. HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages. Proc Natl Acad Sci U S A. 2016;113:5311–5316.
   PubMed Web of Science ®Google Scholar
• Sandhu S, Wu X, Nabi Z, et al. Loss of HLTF function promotes intestinal carcinogenesis. Mol Cancer. 2012;11:18.
   PubMed Web of Science ®Google Scholar
• Lu F, Liu Y, Jiang L, et al. Role of Tet proteins in enhancer activity and telomere elongation. Genes Dev. 2014;28:2103–2119.
   PubMed Web of Science ®Google Scholar
• Zeng S, Xiang T, Pandita TK, et al. Telomere recombination requires the MUS81 endonuclease. Nat Cell Biol. 2009;11:616–623.
   PubMed Web of Science ®Google Scholar
• Vorlickova M, Tomasko M, Sagi AJ, et al. 8-oxoguanine in a quadruplex of the human telomere DNA sequence. Febs J. 2012;279:29–39.
   PubMed Web of Science ®Google Scholar
• McNulty JM, Jerkovic B, Bolton PH, et al. Replication inhibition and miscoding properties of DNA templates containing a site-specific cis-thymine glycol or urea residue. Chem Res Toxicol. 1998;11:666–673.
   PubMed Web of Science ®Google Scholar
• Wang Z, Rhee DB, Lu J, et al. Characterization of oxidative guanine damage and repair in mammalian telomeres. PLoS Genet. 2010;6:e1000951.
   PubMed Web of Science ®Google Scholar
• Fouquerel E, Barnes RP, Uttam S, et al. Targeted and persistent 8-oxoguanine base damage at telomeres promotes telomere loss and crisis. Mol Cell. 2019;75:117–130 e116.
   PubMed Web of Science ®Google Scholar
• Vallabhaneni H, O’Callaghan N, Sidorova J, et al. Defective repair of oxidative base lesions by the DNA glycosylase Nth1 associates with multiple telomere defects. PLoS Genet. 2013;9:e1003639.
   PubMed Web of Science ®Google Scholar